0.89 USD
↗ 0.01 (0.76%)AT CLOSE (11:59 AM EDT)
Werewolf Therapeutics, Inc. Common Stock
HOWLNASDAQ • USD
0.88
↘ 0.01 (1.12%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
0.88
↘ 0.01 (1.12%)
Market: OPEN
Werewolf Therapeutics, Inc. Common Stock (HOWL) is currently trading at $0.88. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest HOWL is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 25, 2026.
Open?$0.87
High?$0.93
Low?$0.84
Prev. Close?$0.88
Volume?6.4M
Avg. Volume?13.0M
VWAP?$0.88
Rel. Volume?0.49x
Bid / Ask
Bid?$0.74 × 100
Ask?$1.20 × 2.2K
Spread?$0.46
Midpoint?$0.97
Valuation & Ratios
Market Cap?42.8M
Shares Out?48.6M
Float?36.2M
Float %?74.4%
P/E Ratio?N/A
P/B Ratio?2.63
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Employees
14
Market Cap
42.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-04-30
Address
200 TALCOTT AVENUE
WATERTOWN, MA 02472
Phone: 617-952-0555
WATERTOWN, MA 02472
Phone: 617-952-0555
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?57
Piotroski F-Score?0/9Weak
Altman Z-Score?-27.52Distress
Confidence?49%Low
Short InterestModerate
Short % of Float?2.95%Low
Short Interest?1.1M
Days to Cover?3.7
Free Float36.2M
Avg Daily Volume288.6K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.91Strong
Quick Ratio?2.91Strong
Cash Ratio?2.80Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.63CHEAP▾
Peers100
S&P62
P/S?2.04CHEAP▾
Peers100
S&P66
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
S&P97
EV/Sales?0.99CHEAP▾
Peers100
S&P92
Returns & Efficiency
ROE?-212.5%WEAK▾
S&P3
ROA?-143.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-30148000
Enterprise Value?$20.8M
Fundamentals ratios updated end of day